Nothing Special   »   [go: up one dir, main page]

AUPO390396A0 - Novel promiscuous T helper cell epitopes - Google Patents

Novel promiscuous T helper cell epitopes

Info

Publication number
AUPO390396A0
AUPO390396A0 AUPO3903A AUPO390396A AUPO390396A0 AU PO390396 A0 AUPO390396 A0 AU PO390396A0 AU PO3903 A AUPO3903 A AU PO3903A AU PO390396 A AUPO390396 A AU PO390396A AU PO390396 A0 AUPO390396 A0 AU PO390396A0
Authority
AU
Australia
Prior art keywords
cell epitopes
helper cell
promiscuous
novel
novel promiscuous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO3903A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland UQ
CSL Ltd
Original Assignee
University of Queensland UQ
CSL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland UQ, CSL Ltd filed Critical University of Queensland UQ
Priority to AUPO3903A priority Critical patent/AUPO390396A0/en
Publication of AUPO390396A0 publication Critical patent/AUPO390396A0/en
Priority to AU51112/98A priority patent/AU5111298A/en
Priority to PCT/AU1997/000820 priority patent/WO1998023635A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AUPO3903A 1996-11-29 1996-11-29 Novel promiscuous T helper cell epitopes Abandoned AUPO390396A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPO3903A AUPO390396A0 (en) 1996-11-29 1996-11-29 Novel promiscuous T helper cell epitopes
AU51112/98A AU5111298A (en) 1996-11-29 1997-12-01 Novel promiscuous t helper cell epitopes
PCT/AU1997/000820 WO1998023635A1 (en) 1996-11-29 1997-12-01 Novel promiscuous t helper cell epitopes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO3903A AUPO390396A0 (en) 1996-11-29 1996-11-29 Novel promiscuous T helper cell epitopes

Publications (1)

Publication Number Publication Date
AUPO390396A0 true AUPO390396A0 (en) 1996-12-19

Family

ID=3798212

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO3903A Abandoned AUPO390396A0 (en) 1996-11-29 1996-11-29 Novel promiscuous T helper cell epitopes

Country Status (2)

Country Link
AU (1) AUPO390396A0 (en)
WO (1) WO1998023635A1 (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1117421T3 (en) * 1998-10-05 2004-11-01 Pharmexa As New methods of therapeutic vaccination
PL202399B1 (en) 1998-10-05 2009-06-30 Pharmexa As Novel methods for therapeutic vaccination
HUP0200958A3 (en) 1999-04-23 2004-11-29 Pharmexa As Method for down-regulating il5 activity
FR2794370B1 (en) 1999-06-03 2003-10-17 Biovector Therapeutics POLYEPITOPIC PROTEIN FRAGMENTS, THEIR OBTAINMENT AND THEIR USES IN PARTICULAR IN VACCINATION
AU778470B2 (en) 1999-07-20 2004-12-09 Pharmexa A/S Method for down-regulating GDF-8 activity
FR2794371B1 (en) * 1999-10-07 2004-06-18 Biovector Therapeutics POLYEPITOPIC PROTEIN FRAGMENTS, THEIR OBTAINMENT AND THEIR USES IN PARTICULAR IN VACCINATION
AU784634B2 (en) 1999-11-30 2006-05-18 Mayo Foundation For Medical Education And Research B7-H1, a novel immunoregulatory molecule
PT1237930E (en) * 1999-12-08 2007-02-28 Intellect Neurosciences Inc Chimeric amyloid beta peptides
MXPA02007796A (en) 2000-02-21 2003-12-08 Pharmexa As Novel method for down regulation of amyloid.
US7030219B2 (en) 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
EP1947174A1 (en) * 2000-06-21 2008-07-23 MedImmune, LLC Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
US6908613B2 (en) * 2000-06-21 2005-06-21 Medimmune, Inc. Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
US7097837B2 (en) 2001-02-19 2006-08-29 Pharmexa A/S Synthetic vaccine agents
AUPR446801A0 (en) 2001-04-18 2001-05-17 University Of Queensland, The Novel compositions and uses therefor
MY144532A (en) 2001-08-20 2011-09-30 Lundbeck & Co As H Novel method for down-regulation of amyloid
US7432351B1 (en) 2002-10-04 2008-10-07 Mayo Foundation For Medical Education And Research B7-H1 variants
TW200509968A (en) 2002-11-01 2005-03-16 Elan Pharm Inc Prevention and treatment of synucleinopathic disease
US8506959B2 (en) 2002-11-01 2013-08-13 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
BRPI0407058A (en) 2003-02-01 2006-01-17 Neuralab Ltd Methods of prophylaxis and treatment of a disease, pharmaceutical composition, and use of a fragment
EA013752B1 (en) 2004-08-09 2010-06-30 Элан Фармасьютикалз, Инк. Prevention and treatment of synucleinopathic and amyloidogenic disease
HUE039237T2 (en) 2004-10-06 2018-12-28 Mayo Found Medical Education & Res B7-h1 and pd-1 in treatment of renal cell carcinoma
JP2008044848A (en) * 2004-11-30 2008-02-28 Univ Kurume Hla-a24-restricted tumor antigen peptide
WO2008042024A2 (en) 2006-06-01 2008-04-10 Elan Pharmaceuticals, Inc. Neuroactive fragments of app
EP2596801B1 (en) 2006-10-06 2018-05-02 Bavarian Nordic A/S Recombinant modified vaccinia ankara virus encoding a her-2 antigen for use in treating cancer
US8440185B2 (en) 2006-12-26 2013-05-14 The Johns Hopkins University Compositions and methods for the treatment of immunologic disorders
US20080206235A1 (en) 2006-12-27 2008-08-28 Johns Hopkins University Compositions and methods for stimulating an immune response
US7989173B2 (en) 2006-12-27 2011-08-02 The Johns Hopkins University Detection and diagnosis of inflammatory disorders
ES2570182T3 (en) 2007-02-23 2016-05-17 Prothena Biosciences Ltd Prevention and treatment of synucleinopathic and amyloidogenic disease
JP5558834B2 (en) 2007-02-23 2014-07-23 ヤンセン アルツハイマー イミュノセラピー Prevention and treatment of synucleinopathies and amyloidogenic diseases
MX2009011127A (en) 2007-04-18 2010-03-10 Janssen Alzheimer Immunotherap Prevention and treatment of cerebral amyloid angiopathy.
JO3076B1 (en) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap Immunotherapy regimes dependent on apoe status
EP2237803B1 (en) 2007-12-28 2015-07-01 Prothena Biosciences Limited Treatment and prophylaxis of amyloidosis
US9011853B2 (en) 2009-08-31 2015-04-21 Amplimmune, Inc. B7-H4 fusion proteins and methods of use thereof
JP2016502507A (en) 2012-10-19 2016-01-28 バヴァリアン・ノルディック・インコーポレイテッド Compositions and methods for cancer treatment
JP6674888B2 (en) 2013-03-13 2020-04-01 プロセナ バイオサイエンシーズ リミテッド Tau immunotherapy
US9302005B2 (en) 2013-03-14 2016-04-05 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
US10259875B2 (en) 2013-10-01 2019-04-16 Mayo Foundation For Medical Education And Research Methods for treating cancer in patients with elevated levels of BIM
JP2017501848A (en) 2013-11-19 2017-01-19 プロセナ バイオサイエンシーズ リミテッド Monitoring immunotherapy of Lewy body disease from constipation symptoms
CA2946606C (en) 2014-05-13 2023-06-06 Bavarian Nordic A/S Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and an antagonist of tim-3
US10302653B2 (en) 2014-05-22 2019-05-28 Mayo Foundation For Medical Education And Research Distinguishing antagonistic and agonistic anti B7-H1 antibodies
US10517875B2 (en) 2014-07-23 2019-12-31 Mayo Foundation for Medical Engineering and Research Targeting DNA-PKcs and B7-H1 to treat cancer
US10875923B2 (en) 2015-10-30 2020-12-29 Mayo Foundation For Medical Education And Research Antibodies to B7-H1
JP7481726B2 (en) 2016-05-02 2024-05-13 プロセナ バイオサイエンシーズ リミテッド Tau recognition antibody
MY197413A (en) 2016-05-02 2023-06-16 Prothena Biosciences Ltd Antibodies recognizing tau
WO2018204546A2 (en) 2017-05-02 2018-11-08 Prothena Biosciences Limited Antibodies recognizing tau
AU2018285412B2 (en) 2017-06-14 2022-06-23 Universität Zürich Cyclic peptides for protection against respiratory syncytial virus
EP3860641A1 (en) 2018-10-05 2021-08-11 Bavarian Nordic A/S Combination therapy for treating cancer with an intravenous administration of a recombinant mva and an immune checkpoint antagonist or agonist
BR112021009856A8 (en) 2018-11-20 2021-09-08 Bavarian Nordic As Therapy for treating cancer with an intratumoral and/or intravenous administration of a recombinant mva encoding 4-1bbl (cd137l) and/or cd40l
WO2020127728A1 (en) 2018-12-20 2020-06-25 Virometix Ag Lipopeptide building blocks and synthetic virus-like particles
SG11202108414UA (en) 2019-03-03 2021-08-30 Prothena Biosciences Ltd Antibodies recognizing tau
EP4061406A1 (en) 2019-11-20 2022-09-28 Bavarian Nordic A/S Recombinant mva viruses for intratumoral and/or intravenous administration for treating cancer
US20230235048A1 (en) 2020-06-24 2023-07-27 Andriani IOANNOU Antibodies recognizing sortilin
WO2021260176A1 (en) 2020-06-25 2021-12-30 Virometix Ag Synthetic epitopes of betacoronaviruses
EP4216992A1 (en) 2020-09-28 2023-08-02 DBV Technologies Particle comprising an rsv-f protein for use in rsv vaccination
EP4452305A1 (en) 2021-12-23 2024-10-30 Bavarian Nordic A/S Recombinant mva viruses for intraperitoneal administration for treating cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9001705D0 (en) * 1990-05-11 1990-05-11 Medscand Ab SET FOR DIAGNOSTICS OF VIRUS BREAKING TUMORS BY IMMUNOASSAY

Also Published As

Publication number Publication date
WO1998023635A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
AUPO390396A0 (en) Novel promiscuous T helper cell epitopes
AU6679598A (en) Chair pack
AU4327197A (en) Chuck
AU1795197A (en) Radiotelephone
AU3739897A (en) Rechargeable positive electrodes
AU5001097A (en) Modular radiotelephone
AU7892694A (en) Battery separator
AU1251797A (en) Novel heteroaryl-oxazolidinones
AU8777898A (en) Methods for genetically modifying t cells
AU5185899A (en) Pack
AU1645397A (en) Lithium cell recharging
AU5185799A (en) Pack
AU6936198A (en) Separator
AU8243798A (en) Agm-derived stroma cells
AU7582598A (en) Chuck
AU3026497A (en) Benzothiazolinones as anti-asthmatic agents
AU8232498A (en) Gripping aid
AU3913895A (en) Sterilization cell
AU3545197A (en) Bioclimatological station
AU2104497A (en) Cell stimulation
AUPO129496A0 (en) Photoelectrochemical cell
AU5111298A (en) Novel promiscuous t helper cell epitopes
AU3276697A (en) Cell compositions
AU3400795A (en) Separator
AUPM473994A0 (en) Separator